Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: Mobilization of Philadelphia-negative peripheral blood stem cells

British Journal of Haematology

Volumn 96, Issue 3, 1997, Pages 627-634

  Chalmers, E A ^a   Franklin, I M ^a   Kelsey, S M ^b   Newland, A C ^b   Clark, R E ^c   Sproul, A M ^a   Crotty, G ^d   Mccann, S R ^d   Fielding, A ^e   Goldstone, A H ^e   Hepplestone, A ^f   Watson, W ^g   Sharp, R A ^h   Tansey, P ^h  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^d ST JAMES S HOSPITAL   (Ireland)

^e UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^f NINEWELLS HOSPITAL   (United Kingdom)

^g MONKLANDS HOSPITAL   (United Kingdom)

^h VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Autologous transplantation; Chronic myeloid leukaemia; Cytarabine; Idarubicin; Peripheral blood stem cells

Indexed keywords

CYTARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; PERIPHERAL BLOOD STEM CELL; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ADULT; CYTARABINE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IDARUBICIN; LEUKEMIA, MYELOID, CHRONIC-PHASE; MALE; MIDDLE AGED; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 8044250273     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1997.d01-2058.x     Document Type: Article

References (23)

1. Allan, N.C., Shepherd. P.C.A. & Richards, S.M. (1995) UK Medical Research Council randomised multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. Lancet, 345, 1392-1397.
2. Arnoldus, E.P.J., Wiegant, J., Noordermeer, I.A., Wessels. J.W., Beverstock. G.C., Grosveld, G.C., van der Ploeg, M. & Raap, A.K. (1990) Detection of the Philadelphia chromosome in interphase nuclei. Cytogenetics and Cell Genetics, 54, 108-112.
3. Barnett, M.J., Eaves, C.J., Phillips, G.L., Gascoyne, R.D., Hogge, D.E., Horseman. D.E., Humphries, R.K., Klingemann. H.G., Lansdorp, P.M., Nantel, S.H., Reece, D.E., Shepherd, J.D., Spinelli, J.J., Sutherland, H.J. & Eaves, A.C. (1994) Autografting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood, 84, 724-732.
4. Butturini, A., Keating, A., Goldman, J.M. & Gale, R.P. (1990) Autotransplants in chronic myeloid leukaemia, Lancet, 335, 1255-1258.
5. Carella, A.M., Frassoni. F., Pollicardo, N., Pungolino, E., Podesta, M., Giordano, D., Ferrero, R., Soracco, M., Benvenuto, F. & Figgari, O. (1994) Ph-negative blood progenitor cells (BPCs) can be recruited after chemotherapy and G-CSF during early haemopoietic recovery in patients at diagnosis of CML or pretreated only with hydroxyurea. Bone Marrow Transplantation, 14, (Suppl. 3), S34-S35.
6. Carella, A.M., Podesta, M., Frassoni, F., Pungolino, E., Pollicardo, N., Raffo. M.R., Ferrero, R., Benvenuto, E. Figari, O., Giordano. D., Lercari. G., Carlier, P., Valbonesi. V., Parodi. M., Gallamini, A., Saglio, G. & Marmont, A.M. (1993a) Selective overshoot of Phnegative blood haemopoietic eels after intensive idarubicin containing regimen and their repopulating capacity after reinfusion. Stem Cells. 11, (Suppl. 3). 67-72.
7. Carella, A.M., Pollicardo, N., Pungolino, E., Raffo. M.R., Podesta, M., Ferrero. R., Pierluigi, D., Nati, S., Naibo, K., Congui, A., Spriano, M., Vimercati, R., Figari. O., Rosso, C., Saglio. G., Sessarego, M., Lercari. G., Valbonesi. M., Carlier. P., Vitale. V., Corvo, P. & Parodi. M. (1993b) Mobilization of cytogenetically 'normal' blood progenitor cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia. Leukemia and Lymphoma, 9, 477-483.
8. Carlo-Stella, C., Mangoni. L., Piovani, G., Almici, C., Garau, D., Caramatti. C. & Rizzoli, V. (1991) In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte-macrophage colony stimulating factor. Bone Marrow Transplantation, 8, 265-273.
9. Cross, N.C., Hughes, T.P., Feng. L., O'Shea, P., Bungey. J., Marks, D.I., Ferrant, A., Martiat, P. & Goldman, J.M. (1993) Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse. British Journal of Haematology. 84, 67-74.
10. Garicochea. B., Chase, A., Lazaridou, A. & Goldman. J.M. (1994) T lymphocytes in chronic myeloid leukemia (CML): no evidence of the BCR/ABL fusion gene detected by fluorescence in situ hybridization in 14 patients. Leukemia. 8, 1197-1201.
11. Hoyle, C., Gray, R. & Goldman, J.M. (1994) Autografting for patients with CML in chronic phase: an update. British Journal of Haematology, 86, 76-81.
12. Italian Cooperative Study Group on Chronic Myeloid Leukaemia (1994) Interferon alpha-2α as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New England Journal of Medicine, 330, 820-825.
13. Kantarjian, H.M., Deisseroth, A., Kurzrock. R., Estrov, Z. & Talpaz, M. (1993) Chronic myeloid leukemia: a concise update. Blood. 82. 691-703.
14. Kantarjian. H.M., Talpaz, M., Hester, J., Feldman. E., Korbling, M., Liang. J., Rios, M.B., Smith. T.L., Calvert, L. & Deisseroth, A.B. (1995) Collection of peripheral blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive dose chemotherapy. Journal of Clinical Oncology, 13, 553-559.
15. Kirkland, M.A., O'Brien, S.G., McDonald, C., Davidson, R.J., Cross, N.C.P. & Goldman, J.M. (1993) BCR-ABL antisense purging in chronic myeloid leukaemia. (Letter). Lancet, 342, 614.
16. Leemhuis, T., Leibowitz, D., Cox. G., Silver, R., Srour. E.F., Tricot. G. & Hoffman, R. (1993) Identification of BCR/ABL negative primitive hemopoietic progenitor cells within chronic myeloid leukemia marrow. Blood, 81, 801-807.
17. Martiat, P., Maisin, D., Philippe, M., Ferrant, A., Michaux, J.L., Cassiman, J.J., Van den Berghe, H. & Sokal. G. (1990) Detection of residual BCR/ABL transcripts in chronic myeloid leukaemia patients in complete remission using the polymerase chain reaction and nested primers. British Journal of Haematology, 75, 355-358.
18. McGlave, P.B., De Fabritiis, P., Deisseroth, A., Goldman, J.M., Barnett, M., Reiffers, J., Simonsson, B., Carella, A. & Aeppli. D. (1994) Autologous transplant therapy for chronic myeloid leukaemia prolongs survival: results from eight transplant groups. Lancet, 343. 1486-1491.
19. Mills. K.I., Hynds, S.A., Burnett, A.K., MacKenzie, E.D. & Birnie, G.D. (1989) Further evidence that the site of the breakpoint in the major breakpoint cluster region (M-ber) may be a prognostic indicator. Leukemia, 3, 837-841.
20. Richman, C.M., Weiner, R.S. & Yankee, R.A. (1977) Increase in circulating stem cells following chemotherapy in man. Blood, 47, 1031-1039.
21. + hemopoietic stem cells in the peripheral blood of high-dose cyclophosphamide treated patients: enhancement by intravenous granulucyte-macrophagecolony-stimulating factor. Blood, 74, 1905-1914.
22. Spencer, A., O'Brien, S.G. & Goldman, J.M. (1995) Options for therapy in chronic myeloid leukaemia. British Journal of Haematology, 91, 2-7.
23. Talpaz, M., Kantarjian, H., Liang, J., Calvert, L., Hamer. J., Tibbits, P., Durett, A., Claxton, D., Giralt. S., Khouri. I., Przepiorka, D., Besien. K.V., Anderson, B., Mehra, R., Gajewski, J., Seong, D., Hester, J., Hstey, E., Korbling, M., Pollicardo, N., Berenson, R., Heinfield, S., Champlin, R. & Deisseroth, A.B. (1995) Percentage of Philadelphia chromosome (Ph)-negative and Ph-positive cells found after autologous transplantation for chronic myeloid leukemia depends on the percentage of diploid cells induced by conventional-dose chemotherapy before collection of autologous cells. Blood. 85, 3257-3263